Evaluation of Bauhinia ungulata Essential Oil as a New Acetylcholinesterase Inhibitor from an in silico and in vitro Perspective in the Northern Amazon of Brazil-Reference-Cited by-同舟云学术

Evaluation of Bauhinia ungulata Essential Oil as a New Acetylcholinesterase Inhibitor from an in silico and in vitro Perspective in the Northern Amazon of Brazil

Published:2024 Issue:8 Volume:73 Page:1091-1104
ISSN:1345-8957
Container-title:Journal of Oleo Science
language:en
Short-container-title:J. Oleo Sci.

Author:

Medeiros Sandra Regina Nunes de Andrade¹²,Bezerra Iverson Conrado²,Pedroza Lucas Aleixo Leal²,Silva Artur José da²,Martins Regildo Max Gomes³,Menezes Thaís Meira⁴,Gonçalves Reis de Melo Ana Cristina⁵,Neves Jorge L.⁶,Gubert Priscila²⁷,Filho Antonio Alves de Melo¹⁵⁸

Affiliation:

1. Biodiversity and Biotechnology of the Legal Amazon, PPG Bionorte, Federal University of Roraima (UFRR)

2. Keizo Asami Institute, Federal University of Pernambuco (UFPE)

3. Biotechnology Multi-Institutional Program, PPGBIOTEC, Federal University of Amazonas (UFAM)

4. Engineering Campus – Academic Unit of Cabo de Santo Agostinho; Federal Rural University of Pernambuco (UFRPE)

5. Environmental Chemistry Laboratory, Center for Research and Postgraduate in Science and Technology, Federal University of Roraima (UFRR)

6. Biological Chemistry Laboratory, Department of Fundamental Chemistry, Federal University of Pernambuco (UFPE)

7. Graduate Program in Biology Applied to Health, Federal University of Pernambuco

8. Postgraduate Program in Biotechnology and Biodiversity of Amazon, Environmental Chemistry Laboratory, Department of Chemistry, Center for Research and Postgraduate in Science and Technology, Federal University of Roraima (UFRR)

Publisher

Japan Oil Chemists' Society

Link

https://www.jstage.jst.go.jp/article/jos/73/8/73_ess23148/_pdf

Reference54 articles.

1. 1) Dugger, B.N.; Dickson, D.W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9, a028035 (2017). doi: 10.1101/cshperspect.a028035

2. 2) Vidal, C.; Zhang, L. An analysis of the neurological and molecular alterations underlying the pathogenesis of Alzheimer’s disease. Cells 10, 546 (2021). doi: 10.3390/cells10030546

3. 3) Atri, A. The Alzheimer’s disease clinical spectrum: Diagnosis and management. Med. Clin. North Am. 103, 263-293 (2019). doi: 10.1016/j.mcna.2018.10.009

4. 4) Wimo, A.; Seeher, K.; Cataldi, R.; Cyhlarova, E.; Dielemann, J.L. et al. The worldwide costs of dementia in 2019. Alzheimer’s Dement. 19, 2865-2873 (2023). doi: 10.1002/alz.12901

5. 5) Trushina, E.; Mielke, M.M. Recent advances in the application of metabolomics to Alzheimer’s disease. Biochim. Biophys. Acta - Mol. Dis. 1842, 1232-1239 (2014). doi: 10.1016/j.bbadis.2013.06.014